BEAT-Lupus trial hits 50% recruitment milestone

The UK’s first clinical trial testing a biological combination treatment for patients with the chronic autoimmune disease, systemic lupus erythematosus (SLE), has successfully met its 50% recruitment target.

The BEAT-Lupus study is a randomised Phase II clinical trial, supported by the NIHR Joint and Related Inflammatory Diseases Translational Research Collaboration. It is funded by Arthritis Research UK in partnership with the UCL Hospitals NIHR Biomedical Research Centre and GSK.

The study will recruit 50 patients from 16 lupus specialist centres across the UK.

Read more